Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

NCT05004025 is registered in ClinicalTrials.gov with HonorHealth Research Institute as lead sponsor.

NCT NCT05004025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05004025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
Lead sponsor
HonorHealth Research Institute
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2022
Completion date
July 23, 2025
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uveal melanoma